You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostatic Neoplasms, Castration-Resistant

Showing 26 - 50 of 7,136
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Prostate Cancer Trial (HRS-5041)

Not yet recruiting
  • Advanced Prostate Cancer
  • (no location specified)
Jul 5, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +7 more
Oct 10, 2023

Radium-223 Treated Castration Resistant Prostate Cancer Bone

Completed
  • Castration-Resistant Prostatic Cancer
  • Radium-223 dichloride, (Xofigo, BAY88-8223)
  • Multiple Locations, Germany
    (unnamed)
Nov 1, 2021

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • Brisbane, Queensland, Australia
    Royal Brisbane & Women's Hospital
Feb 9, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Castration-Resistant Prostate Cancer Trial (SHR3680 tablets)

Not yet recruiting
  • Castration-Resistant Prostate Cancer
  • SHR3680 tablets
  • (no location specified)
Nov 1, 2022

Hormone-refractory Prostate Cancer Trial (AMX-500)

Not yet recruiting
  • Hormone-refractory Prostate Cancer
  • (no location specified)
Aug 11, 2023

Castration Resistant Prostatic Cancer Trial in Australia (Docetaxel intermittent, Docetaxel standard of care)

Recruiting
  • Castration Resistant Prostatic Cancer
  • Docetaxel intermittent
  • Docetaxel standard of care
  • Albury, New South Wales, Australia
  • +4 more
Feb 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Prostate Cancer Trial in Beijing, Nanjing (QLH12016)

Not yet recruiting
  • Prostate Cancer
  • Beijing, Beijign, China
  • +1 more
Jul 25, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Disitamab Vedotin（RC48-ADC）
  • (no location specified)
Jul 13, 2023

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Metastatic Prostate Cancer in Brazilian Population - Analysis of

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
    • Porto Alegre, RS, Brazil
    • +7 more
    Jun 24, 2022

    Prospective Androgen Receptor Signaling Inhibitors Resistance

    Not yet recruiting
    • Prostate Cancer
    • +3 more
      • (no location specified)
      Nov 15, 2023

      Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • (no location specified)
      Feb 28, 2023

      Prostatic Tumors, Exercise, Castration-resistant Prostate Cancer Trial in Ghent (Exercise)

      Completed
      • Prostatic Neoplasms
      • +3 more
      • Exercise
      • Ghent, Oost-Vlaanderen, Belgium
        University Hospital ghent
      Dec 22, 2022

      Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

      Recruiting
      • Advanced Solid Tumor
      • +26 more
      • Baltimore, Maryland
      • +3 more
      Aug 1, 2022

      Overall Survival and Effectiveness Predictors for mCRPCReal Life

      Completed
      • Prostatic Neoplasms, Castration-Resistant
      • Radium-223-dichloride (Xofigo, BAY88-8223)
      • Multiple Locations, Germany
        Many Locations
      Nov 1, 2021

      Darolutamide, Enzalutamide and Apalutamide and How Well These

      Not yet recruiting
      • Non-metastatic Castration-resistant Prostate Cancer
      • Whippany, New Jersey
        Bayer
      Aug 25, 2023

      Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

      Not yet recruiting
      • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
      • Sipuleucel-T
      • Oklahoma City, Oklahoma
        Stephenson's Cancer Center
      Mar 28, 2023

      PRostate Olaparib Real World Evidence Study

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
        • (no location specified)
        Sep 4, 2023

        Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

        Active, not recruiting
        • Prostatic Neoplasms
        • Beijing, China
        • +3 more
        Jan 17, 2023

        Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)

        Recruiting
        • Metastatic Castration-resistant Prostate Cancer, mCRPC
        • Seoul, Korea, Republic of
          The Catholic University of Korea, Seoul, St, Mary's Hospital, 22
        Dec 8, 2022